Filing Details

Accession Number:
0001225208-20-006282
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-04-08 16:18:59
Reporting Period:
2020-04-07
Accepted Time:
2020-04-08 16:18:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1099800 Edwards Lifesciences Corp EW Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 364316614
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1204551 A Michael Mussallem One Edwards Way
Irvine CA 92614
Chairman & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-04-07 32,850 $35.79 69,976 No 4 M Direct
Common Stock Disposition 2020-04-07 400 $197.57 69,576 No 4 S Direct
Common Stock Disposition 2020-04-07 415 $194.91 69,161 No 4 S Direct
Common Stock Disposition 2020-04-07 700 $206.14 68,461 No 4 S Direct
Common Stock Disposition 2020-04-07 800 $197.16 67,661 No 4 S Direct
Common Stock Disposition 2020-04-07 905 $196.15 66,756 No 4 S Direct
Common Stock Disposition 2020-04-07 1,300 $200.26 65,456 No 4 S Direct
Common Stock Disposition 2020-04-07 2,000 $199.27 63,456 No 4 S Direct
Common Stock Disposition 2020-04-07 2,300 $202.40 61,156 No 4 S Direct
Common Stock Disposition 2020-04-07 2,400 $201.21 58,756 No 4 S Direct
Common Stock Disposition 2020-04-07 3,499 $203.35 55,257 No 4 S Direct
Common Stock Disposition 2020-04-07 3,731 $204.29 51,526 No 4 S Direct
Common Stock Disposition 2020-04-07 4,400 $205.20 47,126 No 4 S Direct
Common Stock Disposition 2020-04-07 10,000 $0.00 37,126 No 5 G Direct
Common Stock Acquisiton 2020-04-07 10,000 $0.00 881,194 No 5 G Indirect By Living Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 5 G Direct
No 5 G Indirect By Living Trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Acquire) Disposition 2020-04-07 32,850 $0.00 32,850 $35.79
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
32,850 2013-06-14 2020-05-13 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 123,920 Indirect 401(k)
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2019.
  2. This transaction was executed in multiple trades at prices ranging from $197.45 to $197.655. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades at prices ranging from $194.62 to $195.58. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
  4. This transaction was executed in multiple trades at prices ranging from $205.84 to $206.415. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
  5. This transaction was executed in multiple trades at prices ranging from $196.735 to $197.34. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
  6. This transaction was executed in multiple trades at prices ranging from $195.735 to $196.45. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
  7. This transaction was executed in multiple trades at prices ranging from $199.76 to $200.74. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
  8. This transaction was executed in multiple trades at prices ranging from $198.71 to $199.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
  9. This transaction was executed in multiple trades at prices ranging from $201.80 to $202.77. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
  10. This transaction was executed in multiple trades at prices ranging from $200.79 to $201.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
  11. This transaction was executed in multiple trades at prices ranging from $202.81 to $203.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
  12. This transaction was executed in multiple trades at prices ranging from $203.81 to $204.74. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
  13. This transaction was executed in multiple trades at prices ranging from $204.83 to $205.79. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
  14. Shares represented on the most recent statement of Issuer's 401(k) Plan Administrator.